Cynvenio Biosystems, Inc., a diagnostics company dedicated to enabling the new era of individualized medicine for all cancer patients, recently announced the availability of the ConcordiaT cell-free DNA (cfDNA) purification sample...

New trial is open to patients who have completed standard treatments; Goal is to determine if cancer recurrences can be detected earlier and lead to improved targeted outcomes. Cynvenio Biosystems, Inc., a diagnostics company dedicated to...